Promise Bio Emerges from Stealth Backed by Pfizer and AstraZeneca
Promise Bio, a Tel Aviv-based biotech startup, has emerged from stealth with an $8.3 million seed round. The company, co-founded by Ronel Veksler, uses an AI-powered platform to detect Post-Translational Modifications (PTMs) in proteins, offering precision medicine solutions for autoimmune diseases.
Promise Bio, a Tel Aviv-based biotech startup, has emerged from stealth with an $8.3 million seed round. The company, co-founded by Ronel Veksler, uses an AI-powered platform to detect Post-Translational Modifications (PTMs) in proteins, offering precision medicine solutions for autoimmune diseases.